Circulating Tumor HPV DNA in Patients With Head and Neck Carcinoma

被引:5
|
作者
Mijares, Kevin [1 ]
Ferrandino, Rocco [2 ]
Chai, Raymond [2 ]
Roof, Scott [2 ]
Bhardwaj, Swati [3 ]
Posner, Marshall [4 ]
Westra, William H. [3 ,5 ]
机构
[1] Mt Sinai West, Dept Pathol, New York, NY USA
[2] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Icahn Sch Med, New York, NY USA
[3] Mt Sinai Hosp, Dept Pathol, Icahn Sch Med, New York, NY USA
[4] Mt Sinai Hosp, Icahn Sch Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[5] 1468 Madison Ave,Annenberg Bldg 15-54, New York, NY 10029 USA
关键词
liqued biopsy; HPV-associated head and neck cancer; oropharyngeal squamous cell carcinoma; human papillomavirus; NavDx; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CARCINOMA; SURROGATE MARKER; PLASMA; CANCER; SYSTEM;
D O I
10.1097/PAS.0000000000002134
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Circulating tumor human papillomavirus DNA (ctHPVDNA) testing using digital-droplet polymerase chain reaction (PCR) detects fragments of tumor-modified human papillomavirus (HPV) in the plasma of patients with HPV-associated head and neck squamous cell carcinomas (HNSCCs). Its impact on tumor surveillance and primary diagnosis is limited by unresolved issues relating to sensitivity and specificity. The study population consisted of patients with HNSCC who had undergone ctHPVDNA testing. HPV status was determined by p16 immunohistochemistry and PCR-HPV genotyping on the tumor samples. For discrepant cases (HPV-positive/ctHPVDNA-negative), HPV status was confirmed by RNA in situ hybridization and, when possible, targeted single-nucleotide polymorphisms genotyping. A total of 167 patients had ctHPVDNA testing, and 141 tumors were HPV positive by p16 immunohistochemistry and PCR genotyping. Genotypes included types 16 (91.5%), 33 (4.3%), 35 (2.1%), and 18 (2.1%). ctHPVDNA was detected in 133 (94.3%) of HPV-positive HNSCCs but in none of the HPV-negative HNSCCs. Four of the 5 p16-positive cases that were negative by PCR and ctHPVDNA were positive by RNA in situ hybridization, and in 2 of these cases, rare high-risk genotypes were identified. ctHPVDNA had a sensitivity of 91.7%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 63.6%. The likelihood that patients with HPV-positive HNSCC have detectable ctHPVDNA is high. Non-HPV16 genotypes contribute to discrepancies but only in a small subset of cases. This finding validates ongoing efforts to use ctHPVDNA as a surveillance tool, and even as a primary diagnostic assay in patients presenting with masses in the neck and/or oropharynx.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [41] Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach
    Honore, N.
    Galot, R.
    van Marcke, C.
    Helaers, R.
    Mendola, A.
    Limaye, N.
    Machiels, J-P.
    ORAL ONCOLOGY, 2021, 118
  • [42] Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?
    Ghiyasimoghaddam, Negin
    Shayan, Navidreza
    Mirkatuli, Hanieh Alsadat
    Baghbani, Mohammadhasan
    Ameli, Nima
    Ashari, Zeynab
    Mohtasham, Nooshin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [43] HPV Prevalence in HIV Patients with Head and Neck Squamous Cell Carcinoma
    Picard, Annabelle
    Badoual, Cecile
    Hourseau, Muriel
    Halimi, Caroline
    Pere, Helene
    Barry, Beatrix
    Albert, Sebastien
    MODERN PATHOLOGY, 2016, 29 : 327A - 327A
  • [44] HPV Prevalence in HIV Patients with Head and Neck Squamous Cell Carcinoma
    Picard, Annabelle
    Badoual, Cecile
    Hourseau, Muriel
    Halimi, Caroline
    Pere, Helene
    Barry, Beatrix
    Albert, Sebastien
    LABORATORY INVESTIGATION, 2016, 96 : 327A - 327A
  • [45] Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma
    Liu, Kun
    Chen, Nanxiang
    Wei, Jian
    Ma, Lin
    Yang, Shiming
    Zhang, Xinxin
    ONCOLOGY REPORTS, 2020, 43 (05) : 1525 - 1535
  • [46] Adenosquamous Carcinoma of the Head and Neck: Relationship to HPV
    Masand, R. P.
    El-Mofty, S. K.
    Lewis, J. S., Jr.
    LABORATORY INVESTIGATION, 2010, 90 : 276A - 276A
  • [47] Adenosquamous Carcinoma of the Head and Neck: Relationship to HPV
    Masand, R. P.
    El-Mofty, S. K.
    Lewis, J. S., Jr.
    MODERN PATHOLOGY, 2010, 23 : 276A - 276A
  • [48] Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients
    Mes, Steven W.
    Brink, Arjen
    Sistermans, Erik A.
    Straver, Roy
    Oudejans, Cees B. M.
    Poell, Jos B.
    Leemans, C. Rene
    Brakenhoff, Ruud H.
    ORAL ONCOLOGY, 2020, 109
  • [49] Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients
    Joost H. van Ginkel
    Manon M. H. Huibers
    Robert J. J. van Es
    Remco de Bree
    Stefan M. Willems
    BMC Cancer, 17
  • [50] Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients
    van Ginkel, Joost H.
    Huibers, Manon M. H.
    van Es, Robert J. J.
    de Bree, Remco
    Willems, Stefan M.
    BMC CANCER, 2017, 17